FB

In our 20th year, DM Clinical delivers a 30+ site, multi-therapeutic network powered by world-class infrastructure. With centralized startup, contracts, and budget services, we free our sites to focus on what matters most – patients – getting a site up and ready within 30-45 days, and delivering faster, more scalable, and patient-centered research solutions. With a team of dedicated recruiters, experienced coordinators and site managers, we take pride in making sure that we can meet or exceed sponsor expectations.

MULTI-THERAPEUTIC NETWORK

National Footprint

Vaccines-c

Arizona

Phoenix

Florida

Bradenton, Doral

Illinois

Chicago

Indiana

Indianapolis

Louisiana

Shreveport

Massachusetts

Boston

Michigan

Detroit

New Jersey

Jersey City

New Mexico

Albuquerque

New York

Brooklyn

Pennsylvania

Philadelphia

Texas

Dallas, Houston, San Antonio

Washington

Seattle

MULTI-SPECIALITIES

Therapeutic Expertise

Vaccines-c

Cardiology

Vaccines-c

Endocrine & Metabolism

Vaccines-c

Gastroenterology

Vaccines-c

General Medicine

Vaccines-c

Infectious Disease

Vaccines-c

Neurology

Vaccines-c

Obesity

Vaccines-c

Ophthalmology

Vaccines-c

Pain

Vaccines-c

Pediatrics

Vaccines-c

Psychiatry

Vaccines-c

Pulmonology

Vaccines-c

Rheumatology

Vaccines-c

Vaccine

Vaccines-c

Women's Health

DM CLINICAL BY THE NUMBERS

Metrics

4.7 Days

Reg Doc/IRB
Submission Time

95%

Diary
Compliance

4.9 Days

Contract Turnaround Time

1.2 Days

Feasibility Turnaround Time

30+

Research
Sites

6.8 Hours

SAE
Turnaround Time

20 Years

of organized & reliable experience

20K+

Subjects
Enrolled

1.97M

Patient
Database

180+

Dedicated
Patient Recruiters

21 Days

From
award to FIP

WHY DM CLINICAL?

Centralized Services

Z

Quality & Regulatory

Centralized Regulatory Oversight:

Faster start-up via Florence & CRIO e-source

15 Onsite QA Specialists:

Real-time quality compliance across sites

 

Enrollment & Retention

200-Seat Call Center:

Accelerates outreach and pre-screening for faster timelines

Project Management:

Drives start-up through retention success

Single Budget & Contract:

24-hour CTA turnaround time speeds up trial launch

Patient Engagement

In-House Marketing:

Rapid enrollment with real-time engagement

Diverse Site Network:

Broad reach for greater inclusion and minority recruitment

Tech & Innovation

Technology Driven Efficiency:

In-house tools for pre-screening, study visibility & custom apps for HCPs/patients

RECENT SUCCESS

Successful Outcomes at a Glance

We have successfully completed over 1,000 studies and have enrolled more than 20,000 patients.
COVID19-Vaccine

Pediatric Obesity

450% Enrollment Goal
23% of Randomizations
90% Retention Rate
Vaccines 2

Influenza Vaccine

216% Enrollment Goal
26% of Randomizations
99.3% Retention Rate
Vaccines 2

Hypercholesterolemia

460% Enrollment Goal
93.5% Retention Rate

 

COVID19-Vaccine

Herpes Zoster Vaccine

186% Enrollment Goal
30% of Randomizations
94.6% Retention Rate
type2-diabetes

Gout

119% Enrollment Goal
3 Sites Were Tope Enrollers
96.8% Retention Rate

 

Vaccines 2

Dyslipidemia LDL_C

383% Enrollment Goal
Top Enroller in Entire Study
100% Retention Rate

DM Clinical

Advancing medicine through innovation and dedication.